Idexx Laboratories Stock Fundamentals
| IDXX Stock | USD 459.86 3.80 0.82% |
IDEXX Laboratories fundamentals help investors to digest information that contributes to IDEXX Laboratories' financial success or failures. It also enables traders to predict the movement of IDEXX Stock. The fundamental analysis module provides a way to measure IDEXX Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IDEXX Laboratories stock.
At this time, IDEXX Laboratories' Net Income is fairly stable compared to the past year. Income Tax Expense is likely to rise to about 233.1 M in 2025, whereas Interest Expense is likely to drop slightly above 11 M in 2025. IDEXX | Select Account or Indicator |
IDEXX Laboratories Company Profit Margin Analysis
IDEXX Laboratories' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current IDEXX Laboratories Profit Margin | 0.23 % |
Most of IDEXX Laboratories' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IDEXX Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
IDEXX Profit Margin Historical Pattern
Today, most investors in IDEXX Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various IDEXX Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's profit margin growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of IDEXX Laboratories profit margin as a starting point in their analysis.
IDEXX Laboratories Profit Margin |
| Timeline |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
IDEXX Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, IDEXX Laboratories has a Profit Margin of 0.2278%. This is 102.03% lower than that of the Health Care Equipment & Supplies sector and 101.96% lower than that of the Health Care industry. The profit margin for all United States stocks is 117.94% lower than that of the firm.
IDEXX Laboratories Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IDEXX Laboratories's current stock value. Our valuation model uses many indicators to compare IDEXX Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IDEXX Laboratories competition to find correlations between indicators driving IDEXX Laboratories's intrinsic value. More Info.IDEXX Laboratories is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.39 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for IDEXX Laboratories is roughly 2.54 . At this time, IDEXX Laboratories' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IDEXX Laboratories' earnings, one of the primary drivers of an investment's value.IDEXX Laboratories' Earnings Breakdown by Geography
IDEXX Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IDEXX Laboratories' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics of similar companies.IDEXX Laboratories is currently under evaluation in profit margin category among its peers.
IDEXX Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, IDEXX Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to IDEXX Laboratories' managers, analysts, and investors.Environmental | Governance | Social |
IDEXX Fundamentals
| Return On Equity | 0.58 | ||||
| Return On Asset | 0.23 | ||||
| Profit Margin | 0.23 % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 38.41 B | ||||
| Shares Outstanding | 81.33 M | ||||
| Shares Owned By Insiders | 1.19 % | ||||
| Shares Owned By Institutions | 92.80 % | ||||
| Number Of Shares Shorted | 1.96 M | ||||
| Price To Earning | 61.31 X | ||||
| Price To Book | 23.64 X | ||||
| Price To Sales | 9.60 X | ||||
| Revenue | 3.9 B | ||||
| Gross Profit | 2.38 B | ||||
| EBITDA | 1.13 B | ||||
| Net Income | 887.87 M | ||||
| Cash And Equivalents | 114.36 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 265.62 M | ||||
| Debt To Equity | 3.27 % | ||||
| Current Ratio | 0.89 X | ||||
| Book Value Per Share | 19.55 X | ||||
| Cash Flow From Operations | 929 M | ||||
| Short Ratio | 2.87 X | ||||
| Earnings Per Share | 10.67 X | ||||
| Price To Earnings To Growth | 4.63 X | ||||
| Target Price | 501.62 | ||||
| Number Of Employees | 11 K | ||||
| Beta | 1.37 | ||||
| Market Capitalization | 37.4 B | ||||
| Total Asset | 1.89 B | ||||
| Retained Earnings | 5.33 B | ||||
| Working Capital | 331.98 M | ||||
| Current Asset | 821.63 M | ||||
| Current Liabilities | 856.76 M | ||||
| Net Asset | 1.89 B |
About IDEXX Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IDEXX Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 33.8 M | 25.5 M | |
| Total Revenue | 3.9 B | 4.1 B | |
| Cost Of Revenue | 1.5 B | 1.6 B | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.11 | 0.09 | |
| Research And Ddevelopement To Revenue | 0.06 | 0.07 | |
| Capex To Revenue | 0.03 | 0.03 | |
| Revenue Per Share | 47.35 | 49.72 | |
| Ebit Per Revenue | 0.29 | 0.30 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.